Meet Us at CPHI FRANKFURT | 28–30 October 2025 | Messe Frankfurt | Vamsi Pharma Pvt. Ltd.

About Us

Your reliable Inhalation Partner for the Long Term alliance

Founded in 2015, Vamsi Pharma Pvt. Ltd. has established itself as a trusted partner in the pharmaceutical industry, specializing in the development and manufacturing of orally inhaled & nasal drug products (OINDP). Over the years, we have grown into a dual-role organization—functioning both as a Contract Research Organization (CRO) and a Contract Development and Manufacturing Organization (CDMO)—with a sharp focus on delivering inhalation therapies that improve patient outcomes across the globe.

Our WHO-GMP certified facility, located in Hyderabad Telangana, India, is dedicated to advancing inhalation technology with a special emphasis on Dry Powder Inhalers (DPI). From premix development to formulations and device combination products, we provide comprehensive services tailored to meet the diverse needs of pharmaceutical partners.

At Vamsi Pharma, we believe in offer our unique “Concept to Commissioning” model. This approach ensures that every stage of product development—from ideation, research, and formulation to regulatory compliance, scale-up, and market launch—is handled with precision, speed, and cost-effectiveness. We are committed to helping our partners bring innovative, high-quality inhalation products to market faster while maintaining the highest standards of compliance and patient safety.

Our Vision

“To become one of the global leaders in pulmonary drug delivery technologies, products and services through continuous innovation”

Our Mission

  • Provide integrated pulmonary drug delivery solutions.
  • Innovate to deliver cost-effective products and services.
  • Unwavering attention to health and safety in all our operations.

What We Do Differently

End-to-End Inhalation Expertise

We provide complete solutions across the inhalation product lifecycle, with capabilities in both Dry Powder Inhalers (DPI) and service related to Metered Dose Inhalers (MDI).

Robust DPI Product
Portfolio

Our pipeline includes a wide range of DPI formulations and device combinations, designed to meet the evolving demands of global healthcare markets.

Flexible CRO and CDMO Solutions

Whether it’s early-stage research, formulation development, scale-up, or full commercial manufacturing, our flexible business model adapts to the unique needs of each client.

Regulatory-Compliant Global Supply

With a deep understanding of international regulatory requirements, we ensure that every product we develop aligns with the strictest global compliance standards.

Select the fields to be shown. Others will be hidden. Drag and drop to rearrange the order.
  • Image
  • SKU
  • Rating
  • Price
  • Stock
  • Availability
  • Add to cart
  • Description
  • Content
  • Weight
  • Dimensions
  • Additional information
Click outside to hide the comparison bar
Compare